For more information or confidential assistance
Call 800-306-3180

Latest Updates in Taxotere Hair Loss Lawsuits

cancer patient hospital hair loss from chemotherapy
Over 12,340 lawsuits have been filed against Sanofi-Aventis with regard to allegations about complications stemming from the defendants’ chemotherapy drug, Taxotere. The plaintiffs claim that the defendants failed to provide adequate warnings to doctors and patients about the risk of permanent hair loss from this... Read More

Four Cases Chosen as Taxotere Bellwethers

taxotere package
On March 9, four representative cases were chosen as the first to be tried in a series of bellwether trials regarding Sanofi-Aventis’s Taxotere (docetaxel). The drug manufacturer currently faces over 5,600 product liability cases alleging that the drug, prescribed for treatment of breast cancer, causes... Read More

Taxotere Plaintiffs Prevail in Request for MDL

Pursuant to an October 10 transfer order filed by the United States Judicial Panel on Multidistrict Litigation, cases involving claims against the maker of breast cancer drug Taxotere have been consolidated under the supervision of U.S. District Judge Lance Africk in the Eastern District of... Read More

Taxotere Hair Loss Lawsuit Filed by Louisiana Woman

A Louisiana woman filed suit on June 17,  alleging that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow following treatment with the medication. According to the complaint, drug maker Sanofi-Aventis failed in... Read More